As the global swine industry continues to evolve toward higher standards of efficiency and biosecurity, industry platforms that bring together expertise and innovation are becoming increasingly important. This October, GC Biotech will participate in one of the most influential events in the sector — the Leman China Swine Conference & World Swine Industry Expo.

Event Information

• Date: October 18–20, 2025
• Location: Changsha International Convention and Exhibition Center
• Booth: E3156

A Key Platform for Global Swine Industry Collaboration

Guided by the theme “Science · Sharing · Collaboration · Legacy,” this year’s conference is expected to gather leading experts, enterprises, and industry stakeholders from around the world. The event has established itself as a major platform for discussing the future of animal husbandry, particularly in the swine sector.

With a projected 1,000+ exhibitors and over 150,000 professional visitors, the conference will focus on several critical areas, including:

• Disease prevention and control
• Diagnostic technologies
• Nutrition and feeding strategies
• Biosecurity management

For companies involved in animal health and vaccine development, this event offers a valuable opportunity to exchange ideas and explore practical solutions.

GC Biotech’s Focus: Advancing Vaccine Performance Through Adjuvant Innovation

At this year’s exhibition, GC Biotech will present its latest developments under the theme:

“Innovative Adjuvant Technology Driving Vaccine Upgrade”

The company will highlight its saponin-based adjuvants and integrated solution approaches designed to improve vaccine efficacy across different application scenarios.

Particular attention will be given to immune enhancement technologies for key vaccines such as:

• Foot-and-Mouth Disease (FMD)
• Porcine Reproductive and Respiratory Syndrome (PRRS)

These solutions are developed to address practical challenges in vaccine performance, including immune response consistency and cost efficiency.

Key Highlights at the GC Biotech Booth

1. Cost-Efficient Adjuvant Technology

GC Biotech’s veterinary saponin adjuvant, derived from South American Quillaja saponaria, offers a cost per dose below RMB 0.05. This enables vaccine manufacturers to improve immunogenicity while maintaining competitive production costs.

2. Application-Oriented Solution Portfolio

The company provides comprehensive scenario-based solutions covering a wide range of animal vaccines. These include:

• Support for traditional vaccine optimization
• Customization for new vaccine development
• Adaptation to different livestock health management needs

3. On-Site Technical Exchange

During the event, GC Biotech’s technical team will be available to discuss:

• Adjuvant selection strategies
• Immune enhancement mechanisms
• Integration into existing vaccine production workflows

This direct exchange is intended to support partners in making practical and informed technical decisions.

A Continued Commitment to Industry Development

GC Biotech maintains its long-standing philosophy of:

“Innovation Leading, Sharing for Growth”

Through ongoing research and collaboration, the company aims to contribute science-based, scalable solutions to the swine industry, supporting both vaccine manufacturers and livestock producers.

Looking Ahead

As the swine industry faces increasing challenges related to disease control, cost pressure, and sustainability, technologies that enhance vaccine performance will play a crucial role.

GC Biotech’s participation in the 2025 Leman Conference reflects its commitment to engaging with global partners, sharing technical insights, and contributing to the advancement of animal health solutions.

Visitors are welcome to connect with the team at Booth E3156 to explore how adjuvant innovation can support next-generation vaccine development.

https://en.jicangbio.com/gc-biotech-invites-you-to-the-14th-leman-china-swine-conference.html